# FDA Inspection 810140 - Carter BloodCare Paris - December 11, 2012

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-paris/4485cb62-9ad0-4f7f-ac49-4f8bcc454059
Source feed: FDA_Inspections

> FDA Inspection 810140 for Carter BloodCare Paris on December 11, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 810140
- Company Name: Carter BloodCare Paris
- Inspection Date: 2012-12-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1119839 - 2020-02-25](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-paris/73188cb3-78c4-4173-8e89-c33d2ce51778)
- [FDA Inspection 1119839 - 2020-02-25](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-paris/320a1047-ea81-4c1d-9f95-c2d32a58ea7c)
- [FDA Inspection 1041613 - 2018-02-09](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-paris/f97ff368-ef7b-475d-abe6-a33d90a05d68)
- [FDA Inspection 729702 - 2011-06-14](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-paris/9362da29-49db-4d2e-a702-a15ead463ee5)
- [FDA Inspection 604692 - 2009-08-13](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-paris/c50eb9c1-8c1a-49b3-a6cb-552439eaad91)

Company: https://www.keypedia.com/companies/carter-bloodcare-paris/c0bcd295-31c2-48e3-a847-451d545524d7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d